Mirati Therapeutics, Inc. — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2022)

$12.4M

Net Income/Loss (FY2022)

-$740.9M

Total Assets (FY2022)

$1.2B

Total Equity (FY2022)

$996.5M

Cash Flows from Operating Activities (FY2022)

-$570.6M

Source: Mirati Therapeutics, Inc. 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.